市場調査レポート

商品コード

1677950

ヘパリン市場規模、シェア、成長分析：製品タイプ別、投与方法別、供給源別、状態別、製品別、治療法別、流通チャネル別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Heparin Market Size, Share, and Growth Analysis, By Product Type, By Mode of Administration, By Source, By Ingredient, By Availability, By Treatment, By Distribution Channel, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年03月05日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ヘパリンの世界市場規模は2023年に71億米ドルと評価され、2024年の74億1,000万米ドルから2032年には103億7,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは4.3％で成長する見通しです。

世界のヘパリン市場は、主に心血管疾患の有病率の増加、人口の高齢化、外科手術の急増に牽引され、ヘルスケアおよび医薬品分野の重要な構成要素となっています。生活習慣病の増加により、抗凝固剤、特にこれらの疾患の管理に不可欠なヘパリンの需要が高まっています。入院率の上昇や外科的介入といった要因が市場の成長をさらに後押ししています。しかし、規制当局の監視、市場競争、ヘパリン誘発性血小板減少症などの合併症に伴うリスクといった課題が大きな障害となっています。とはいえ、バイオシミラーの開発、ドラッグデリバリー機構の進歩、新興国市場の成長などから生じる機会により、市場の成長は期待されます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Opocrin S.p.A.（Italy）
Baxter International Inc.（U.S.）
Pfizer Inc.（U.S.）
Bioiberica S.A.U.（Spain）
Fresenius SE & Co. KGaA（Germany）
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.（China）
B. Braun SE（Germany）
Dr. Reddy's Laboratories Ltd.（India）
LEO Pharma A/S（Denmark）
Aspen Holdings（South Africa）
Gland Pharma（India）
Hikma Pharmaceuticals（United Kingdom）
Techdow USA（U.S.）
Viatris Inc.（U.S.）
Biological E. Limited（India）
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.（China）
Faran Shimi Pharmaceutical Company（Iran）
Octapharma AG（Switzerland）
Kamada Ltd.（Israel）

結論と提言

Product Code: SQMIG35H2166

Global Heparin Market size was valued at USD 7.1 billion in 2023 and is poised to grow from USD 7.41 billion in 2024 to USD 10.37 billion by 2032, growing at a CAGR of 4.3% during the forecast period (2025-2032).

The global heparin market is a critical component of the healthcare and pharmaceutical sectors, driven primarily by the increasing prevalence of cardiovascular diseases, an aging population, and a surge in surgical procedures. The rising incidence of lifestyle-related illnesses is elevating the demand for anticoagulants, particularly heparin, which is essential for managing these conditions. Factors such as higher hospitalization rates and surgical interventions further bolster market growth. However, challenges such as regulatory scrutiny, market competition, and risks associated with complications, including heparin-induced thrombocytopenia, pose significant hurdles. Nevertheless, the market is expected to thrive due to opportunities arising from the development of biosimilars, advancements in drug delivery mechanisms, and growth in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heparin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Heparin Market Segments Analysis

Global Heparin Market is segmented by Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Unfractionated Heparin, Low Molecular Weight Heparin (LMWH) and Ultra-Low Molecular Weight Heparin (ULMWH). Based on Mode of Administration, the market is segmented into Oral Administration and Parenteral Administration. Based on Source, the market is segmented into Bovine and Porcine. Based on Ingredient, the market is segmented into Sodium, Calcium and Others. Based on Availability, the market is segmented into Raw and Processed. Based on Treatment, the market is segmented into Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism and Others. Based on Therapeutics, the market is segmented into Cardiovascular, Respiratory, Oncology, Nephrology, CNS and Others. Based on Strength, the market is segmented into 10 -1000 Unit, 1000 -5000 Unit, 5000- 25000 Unit and Others. Based on Type, the market is segmented into Generics and Brands. Based on Container, the market is segmented into Bottles, Bags, Vials and Others. Based on Packaging, the market is segmented into Glass and Plastic. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Drug Store, Online Pharmacy and Others. Based on Application, the market is segmented into Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests and Others. Based on End User, the market is segmented into Hospitals, Clinics, Homecare, Ambulatory Surgical Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Heparin Market

The global heparin market is primarily driven by the prevalence of cardiovascular diseases, which remain a leading cause of death and illness worldwide. Conditions such as heart attacks, atrial fibrillation, and strokes significantly heighten the risk of thromboembolic complications, thereby boosting the need for anticoagulants like heparin. Additionally, the rising incidence of pulmonary embolism (PE) and deep vein thrombosis (DVT) further fuels the demand for heparin, as it is widely recognized as the standard treatment for these conditions. As a result, the growing focus on cardiovascular health and related disorders continues to propel the heparin market forward.

Restraints in the Global Heparin Market

The global heparin market faces significant restraints primarily due to the severe side effects associated with heparin therapy, particularly the risk of bleeding, which can lead to patient hesitance and concerns among healthcare providers regarding its use. Additionally, conditions such as Heparin-Induced Thrombocytopenia (HIT) can result in serious complications, thereby undermining the confidence in and safety of heparin treatment. Furthermore, the requirement for continuous monitoring of activated partial thromboplastin time (aPTT) with unfractionated heparin to prevent adverse effects and ensure therapeutic efficacy complicates treatment regimens, particularly in outpatient settings, thereby limiting its wide-scale adoption.

Market Trends of the Global Heparin Market

The global heparin market is experiencing a significant shift with a heavy focus on biosimilars, driven by the expiry of patents for original heparin products. This trend is particularly pronounced in Europe and North America, where healthcare providers seek cost-effective alternatives that maintain safety and efficacy. The rise in biosimilars allows for reduced treatment costs, further enhancing patient access to necessary anticoagulant therapies. As regulatory bodies continue to streamline the approval process for these biosimilars, the heparin market is poised for substantial growth, reflecting a broader move towards cost-efficient healthcare solutions while prioritizing patient outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Heparin Market Size by Product Type & CAGR (2025-2032)

Market Overview
Unfractionated Heparin
Low Molecular Weight Heparin (LMWH)
Ultra-Low Molecular Weight Heparin (ULMWH)

Global Heparin Market Size by Mode of Administration & CAGR (2025-2032)

Market Overview
Oral Administration
Parenteral Administration

Global Heparin Market Size by Source & CAGR (2025-2032)

Market Overview
Bovine
Porcine

Global Heparin Market Size by Ingredient & CAGR (2025-2032)

Market Overview
Sodium
Calcium
Others

Global Heparin Market Size by Availability & CAGR (2025-2032)

Market Overview
Raw
Processed

Global Heparin Market Size by Treatment & CAGR (2025-2032)

Market Overview
Deep Vein Thrombosis
Pulmonary Embolism
Arterial Thromboembolism
Others

Global Heparin Market Size by Therapeutics & CAGR (2025-2032)

Market Overview
Cardiovascular
Respiratory
Oncology
Nephrology
CNS
Others

Global Heparin Market Size by Strength & CAGR (2025-2032)

Market Overview
10 -1000 Unit
1000 -5000 Unit
5000- 25000 Unit
Others

Global Heparin Market Size by Type & CAGR (2025-2032)

Market Overview
Generics
Brands

Global Heparin Market Size by Container & CAGR (2025-2032)

Market Overview
Bottles
Bags
Vials
Others

Global Heparin Market Size by Packaging & CAGR (2025-2032)

Market Overview
Glass
Plastic

Global Heparin Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospital Pharmacy
Retail Pharmacy and Drug Store
Online Pharmacy
Others

Global Heparin Market Size by Application & CAGR (2025-2032)

Market Overview
Pre-Surgical Procedures
Post-Surgical Procedures
Kidney Dialysis
Diagnostic Tests
Others

Global Heparin Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Homecare
Ambulatory Surgical Centres
Others

Global Heparin Market Size & CAGR (2025-2032)

North America (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
- US
- Canada
Europe (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Opocrin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioiberica S.A.U. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LEO Pharma A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspen Holdings (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gland Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Techdow USA (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological E. Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Faran Shimi Pharmaceutical Company (Iran)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Octapharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kamada Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ヘパリン市場規模、シェア、成長分析：製品タイプ別、投与方法別、供給源別、状態別、製品別、治療法別、流通チャネル別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Heparin Market Size, Share, and Growth Analysis, By Product Type, By Mode of Administration, By Source, By Ingredient, By Availability, By Treatment, By Distribution Channel, By Application, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ヘパリン市場規模：製品タイプ別& CAGR（2025-2032）

ヘパリン市場規模：投与方法別& CAGR（2025-2032）

ヘパリン市場規模：供給源別& CAGR（2025-2032）

ヘパリン市場規模：成分別& CAGR（2025-2032）

ヘパリン市場規模：状態別& CAGR（2025-2032）

ヘパリン市場規模：治療別& CAGR（2025-2032）

ヘパリン市場規模：治療域別 & CAGR（2025-2032）

ヘパリン市場規模：強さ別& CAGR（2025-2032）

ヘパリン市場規模：タイプ別& CAGR（2025-2032）

ヘパリン市場規模：容器別& CAGR（2025-2032）

ヘパリン市場規模：包装別& CAGR（2025-2032）

ヘパリン市場規模：流通チャネル別& CAGR（2025-2032）

ヘパリン市場規模：用途別& CAGR（2025-2032）

ヘパリン市場規模：エンドユーザー別& CAGR（2025-2032）

ヘパリン市場規模：地域別& CAGR（2025-2032）